Dr. Rezwan Hossain Chowdhury, MD

Dr. Chowdhury practices at Medical Oncology / Hematology - Shea in Tempe, Arizona.

Dr. Chowdhury's NPI, 1629379565, was assigned on November 9, 2010. Dr. Chowdhury graduated from University of Alberta in 2005. Dr. Chowdhury holds Arizona license 42880.

Dr. Chowdhury's primary practice is Medical Oncology / Hematology - Shea, at 7695 S Research Dr, Tempe, AZ 85284-1812. The practice phone is (480) 278-8300.

Dr. Chowdhury's primary practice is Medical Oncology / Hematology - Shea in Tempe, Arizona. The medical group on file is Arizona Center for Cancer Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chowdhury practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Chowdhury's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Chowdhury is board certified in radiation oncology by the American Board of Radiology. Dr. Chowdhury is licensed in Arizona.

Dmand AI lists bladder cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Chowdhury treats.

CMS data shows 12,724 Medicare services from Dr. Chowdhury across 28 procedure codes in 2024, for 485 Medicare patients. Medicare paid $1,052,041 for them. Every service was in an office.

CMS counts 485 Medicare patients who saw Dr. Chowdhury in 2024. The largest group is 65 to 74, with 253 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chowdhury's median patient age at 69, with 42% women.

In 2024, Dr. Chowdhury wrote 188 Medicare Part D claims for 101 patients. 90% of them were for generic drugs. CMS names the drug for 132 of them, across 6 drugs with 11 or more claims each, at $2,425 in total drug cost. In 2023, CMS named 97 claims across 5 drugs.

Dr. Chowdhury accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Chowdhury in 2015. 2015 was the busiest year, with 2.

Dmand AI links Dr. Chowdhury to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Brain Neoplasms, Breast Neoplasms and Breast Diseases. British Columbia Cancer Agency sponsors the most, 2.

CMS Open Payments shows 267 general payments to Dr. Chowdhury from 71 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Janssen Pharmaceuticals, Inc paid the most, $555.

Dr. Chowdhury graduated from University of Alberta in 2005.

Dr. Chowdhury is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.